MiRTLE Medical LLC — SEC Form D Filing

MiRTLE Medical LLC filed an SEC Form D on June 15, 2026, reporting $590K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 15, 2026
Amount reported
$590K
Industry
Medical Devices
Website
https://mirtlemed.com/

What the company does

Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Current ECG monitors cannot effectively monitor a patient's heart during an MRI scan due to significant electrical interference from the MRI's energy, limiting cardiac visibility for clinicians and preventing certain patients from receiving MRI scans.

Solution

MiRTLE Medical provides MRI-compatible 12-lead ECG monitoring systems and software that eliminate MRI interference through engineered filters and advanced signal processing, allowing diagnostic-grade cardiac monitoring during MRI procedures and expanding the range of patients who can safely undergo an MRI.

Verdict

Investors funded MiRTLE Medical because the technical challenge of MRI-compatible ECG appeared solvable with a focused engineering approach, not because of immediate market demand or a clear go-to-market strategy. They were implicitly betting on the team’s ability to execute a niche engineering solution. This limited upside, as the initial fundraising prioritized solving a technical problem over proving broad commercial viability or scalability within a complex medical device market.

Source: SEC EDGAR Form D filing